| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.28B | 1.33B | 1.39B | 1.10B | 656.67M |
| Gross Profit | 852.75M | 891.71M | 926.91M | 724.29M | 439.81M |
| EBITDA | 251.85M | 186.50M | 321.96M | 294.67M | 93.63M |
| Net Income | -37.23M | -37.68M | 167.16M | 113.00K | -248.72M |
Balance Sheet | |||||
| Total Assets | 2.19B | 2.29B | 2.27B | 2.15B | 2.11B |
| Cash, Cash Equivalents and Short-Term Investments | 134.00M | 83.87M | 36.67M | 34.67M | 26.94M |
| Total Debt | 1.79B | 1.84B | 1.90B | 1.93B | 1.84B |
| Total Liabilities | 2.27B | 2.33B | 2.31B | 2.36B | 2.33B |
| Stockholders Equity | -79.49M | -39.70M | -39.44M | -211.81M | -219.72M |
Cash Flow | |||||
| Free Cash Flow | 92.19M | 79.66M | 145.68M | 32.93M | 28.18M |
| Operating Cash Flow | 140.78M | 162.01M | 209.13M | 107.15M | 61.00M |
| Investing Cash Flow | 12.23M | 69.94M | -72.94M | -55.75M | 40.45M |
| Financing Cash Flow | -102.92M | -185.10M | -134.34M | -43.35M | -91.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
52 Neutral | C$1.52M | 4.43 | -1.44% | ― | -7.90% | 93.35% | |
47 Neutral | $631.92M | 453.21 | ― | ― | 18.50% | 31.15% | |
46 Neutral | C$611.35M | -0.08 | -38.53% | ― | -59.51% | -545.36% | |
43 Neutral | $260.66M | -224.02 | ― | ― | 16.65% | 1.41% | |
41 Neutral | C$6.98M | -0.16 | ― | ― | -11.27% | 57.50% |
Cineplex reported February 2026 box office revenue of $32.4 million, or 93% of the prior year’s February, bringing first-quarter box office to date to 104% of 2025 levels. With no blockbuster releases and weaker contributions from international titles than a year earlier, performance was driven by original films such as Wuthering Heights, GOAT and Send Help, underscoring the importance of a deep and diversified slate.
The company highlighted the strong late-month debut of Scream 7, which delivered the highest opening weekend in the franchise’s history and boosted early March results, reinforcing the enduring draw of long-running series. Management also pointed to unconventional successes like independently funded Iron Lung and flagged a robust upcoming release calendar, including major animated and international titles, as a promising catalyst for audience traffic and box office momentum in the coming months.
The most recent analyst rating on (TSE:CGX) stock is a Sell with a C$9.00 price target. To see the full list of analyst forecasts on Cineplex stock, see the TSE:CGX Stock Forecast page.
Cineplex reported full-year 2025 revenue of $1.28 billion, modestly higher than a year earlier, while narrowing its net loss to $36.9 million as record box office and concession spending per patron helped offset softer attendance and the absence of mega-blockbuster titles. Premium formats and international films reached their highest-ever shares of box office receipts, cinema media revenue rose 13.1% with record media per patron, and the location-based entertainment segment improved profitability.
The company completed the $70 million sale of its Cineplex Digital Media unit, using proceeds in part to repurchase 636,602 shares under its normal course issuer bid and bolster balance sheet flexibility for debt reduction and future capital allocation. Cineplex also announced board changes, with long-serving director Robert Bruce retiring and former Scotiabank Group Head and CFO Sean McGuckin joining the board, a move expected to strengthen financial oversight and support long-term strategic planning ahead of a stronger 2026 film slate.
The most recent analyst rating on (TSE:CGX) stock is a Hold with a C$9.00 price target. To see the full list of analyst forecasts on Cineplex stock, see the TSE:CGX Stock Forecast page.
Cineplex said the Federal Court of Appeal has upheld the Competition Tribunal’s September 2024 ruling over the company’s presentation of its online booking fee, including a $39 million administrative monetary penalty. The company stated it disagrees with the decision, maintains that its online booking fee has always been clearly and prominently disclosed in compliance with the law, and announced it will seek leave to appeal the case to the Supreme Court of Canada, extending a high-profile legal battle with potential financial and reputational implications for the theatre operator and its digital pricing practices.
The most recent analyst rating on (TSE:CGX) stock is a Hold with a C$11.50 price target. To see the full list of analyst forecasts on Cineplex stock, see the TSE:CGX Stock Forecast page.
Cineplex Inc. will publish its fourth quarter and full-year 2025 financial results on February 11, 2026, followed by a webcast at 10:00 a.m. ET hosted by CEO Ellis Jacob and CFO Gord Nelson to review the company’s performance. The event, accessible via an online audio webcast with a subsequent archive, signals an upcoming update for investors and analysts on Cineplex’s operational and financial trajectory across its diversified entertainment and media platforms, with media invited to attend in listen-only mode.
The most recent analyst rating on (TSE:CGX) stock is a Hold with a C$11.50 price target. To see the full list of analyst forecasts on Cineplex stock, see the TSE:CGX Stock Forecast page.
Cineplex reported December 2025 box office revenue of $67.0 million, surpassing the prior year’s December performance and bringing its fourth-quarter box office to 95% of 2024 levels. The company attributed the strong finish to a varied film slate led by Avatar: Fire and Ash, robust demand for premium formats that generated about 90% of that title’s box office, and solid contributions from family and animated releases such as Zootopia 2.
International and alternative content continued to underpin Cineplex’s strategy and market differentiation, with Hindi-language title Dhurandhar becoming the highest-grossing Hindi film ever in North America and generating over 30% of its regional box office through Cineplex locations. Additional momentum came from sold-out theatrical screenings of the Stranger Things series finale and strong December performances from Cineplex Pictures releases The Housemaid and Jujutsu Kaisen: Execution, reinforcing the company’s emphasis on premium, event-style experiences and diverse programming as it heads into 2026 with a robust slate of upcoming releases.
The most recent analyst rating on (TSE:CGX) stock is a Hold with a C$10.50 price target. To see the full list of analyst forecasts on Cineplex stock, see the TSE:CGX Stock Forecast page.